用于纳米药物诱导的癌症免疫疗法的工程金属及其复合物"[Mater.用于纳米药物诱导的癌症免疫疗法的工程金属及其复合物，15，(2022)，100276)

IF 8.1 2区材料科学 Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY

Materials Today Advances Pub Date : 2024-01-04 DOI:10.1016/j.mtadv.2023.100457

Yushu Wang, Bin Wang, Kao Li, Maosheng Wang, Haihua Xiao

引用次数: 0

摘要

无摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to “Engineered metal and their complexes for nanomedicine-elicited cancer immunotherapy” [Mater. Today Adv., Engineered metal and their complexes for nanomedicine-elicited cancer immunotherapy, 15, (2022), 100276]

Abstract not available

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Materials Today Advances MATERIALS SCIENCE, MULTIDISCIPLINARY-

CiteScore

14.30

自引率

2.00%

发文量

116

审稿时长

32 days

期刊介绍： Materials Today Advances is a multi-disciplinary, open access journal that aims to connect different communities within materials science. It covers all aspects of materials science and related disciplines, including fundamental and applied research. The focus is on studies with broad impact that can cross traditional subject boundaries. The journal welcomes the submissions of articles at the forefront of materials science, advancing the field. It is part of the Materials Today family and offers authors rigorous peer review, rapid decisions, and high visibility.